| Year |
Citation |
Score |
| 2024 |
Pressl C, Mätlik K, Kus L, Darnell P, Luo JD, Paul MR, Weiss AR, Liguore W, Carroll TS, Davis DA, McBride J, Heintz N. Selective vulnerability of layer 5a corticostriatal neurons in Huntington's disease. Neuron. PMID 38237588 DOI: 10.1016/j.neuron.2023.12.009 |
0.651 |
|
| 2024 |
Caron NS, Aly AE, Black HF, Martin DDO, Schmidt ME, Ko S, Anderson C, Harvey EM, Casal LL, Anderson LM, Rahavi SMR, Reid GSD, Oda MN, Stanimirovic D, Abulrob A, ... McBride JL, et al. Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington disease. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 38215984 DOI: 10.1016/j.jconrel.2024.01.011 |
0.407 |
|
| 2023 |
Bertoglio D, Weiss AR, Liguore W, Martin LD, Hobbs T, Templon J, Srinivasan S, Dominguez C, Munoz-Sanjuan I, Khetarpal V, Verhaeghe J, Staelens S, Link J, Liu L, Bard JA, ... McBride JL, et al. In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37591545 DOI: 10.2967/jnumed.123.265569 |
0.661 |
|
| 2023 |
Weiss AR, Liguore WA, Brandon K, Wang X, Liu Z, Kroenke CD, McBride JL. Alterations of fractional anisotropy throughout cortico-basal ganglia gray matter in a macaque model of Huntington's Disease. Current Research in Neurobiology. 4: 100090. PMID 37397804 DOI: 10.1016/j.crneur.2023.100090 |
0.68 |
|
| 2023 |
Pressl C, Mätlik K, Kus L, Darnell P, Luo JD, Weiss AR, Liguore W, Carroll TS, Davis DA, McBride J, Heintz N. Layer 5a Corticostriatal Projection Neurons are Selectively Vulnerable in Huntington's Disease. Biorxiv : the Preprint Server For Biology. PMID 37162977 DOI: 10.1101/2023.04.24.538096 |
0.647 |
|
| 2022 |
Weiss AR, Bertoglio D, Liguore WA, Brandon K, Templon J, Link J, McBride JL. Reduced D /D Receptor Binding and Glucose Metabolism in a Macaque Model of Huntington's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 36544385 DOI: 10.1002/mds.29271 |
0.64 |
|
| 2022 |
Weiss AR, Liguore WA, Brandon K, Wang X, Liu Z, Domire JS, Button D, Srinivasan S, Kroenke CD, McBride JL. A novel rhesus macaque model of Huntington's disease recapitulates key neuropathological changes along with motor and cognitive decline. Elife. 11. PMID 36205397 DOI: 10.7554/eLife.77568 |
0.728 |
|
| 2021 |
Chatterjee D, Marmion DJ, McBride JL, Manfredsson FP, Butler D, Messer A, Kordower JH. Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9. Gene Therapy. PMID 33753910 DOI: 10.1038/s41434-021-00244-y |
0.761 |
|
| 2020 |
Weiss AR, Liu Z, Wang X, Liguore WA, Kroenke CD, McBride JL. The macaque brain ONPRC18 template with combined gray and white matter labelmap for multimodal neuroimaging studies of nonhuman primates. Neuroimage. 117517. PMID 33137475 DOI: 10.1016/j.neuroimage.2020.117517 |
0.61 |
|
| 2020 |
Howland D, Ellederova Z, Aronin N, Fernau D, Gallagher J, Taylor A, Hennebold J, Weiss A, Gray-Edwards H, McBride J. Large Animal Models of Huntington's Disease: What We Have Learned and Where We Need to Go Next. Journal of Huntington's Disease. PMID 32925082 DOI: 10.3233/Jhd-200425 |
0.703 |
|
| 2020 |
Weiss AR, Liguore WA, Domire JS, Button D, McBride JL. Intra-striatal AAV2.retro administration leads to extensive retrograde transport in the rhesus macaque brain: implications for disease modeling and therapeutic development. Scientific Reports. 10: 6970. PMID 32332773 DOI: 10.1038/S41598-020-63559-7 |
0.7 |
|
| 2019 |
Liguore WA, Domire JS, Button D, Wang Y, Dufour BD, Srinivasan S, McBride JL. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31420242 DOI: 10.1016/J.Ymthe.2019.07.017 |
0.727 |
|
| 2018 |
Dufour BD, McBride JL. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease. Neurobiology of Disease. PMID 30292559 DOI: 10.1016/J.Nbd.2018.09.025 |
0.74 |
|
| 2018 |
McBride JL, Neuringer M, Ferguson B, Kohama SG, Tagge IJ, Zweig R, Renner LM, McGill TJ, Stoddard J, Peterson S, Su W, Sherman LS, Domire JS, Ducore RM, Colgin LM, et al. Discovery of a CLN7 model of Batten disease in non-human primates. Neurobiology of Disease. PMID 30048804 DOI: 10.1016/J.Nbd.2018.07.013 |
0.355 |
|
| 2016 |
Dufour BD, McBride JL. Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease. Experimental Neurology. PMID 27381424 DOI: 10.1016/J.Expneurol.2016.06.028 |
0.718 |
|
| 2016 |
Dufour BD, McBride JL. Intravascular AAV9 Administration for Delivering RNA Silencing Constructs to the CNS and Periphery. Methods in Molecular Biology (Clifton, N.J.). 1364: 261-75. PMID 26472457 DOI: 10.1007/978-1-4939-3112-5_21 |
0.709 |
|
| 2015 |
Keiser MS, Kordasiewicz H, McBride J. Gene Suppression Strategies for Dominantly Inherited Neurodegenerative Diseases: lessons from Huntington's Disease and Spinocerebellar Ataxia. Human Molecular Genetics. PMID 26503961 DOI: 10.1093/hmg/ddv442 |
0.335 |
|
| 2015 |
Pitzer M, Lueras J, Warden A, Weber S, McBride J. Viral vector mediated expression of mutant huntingtin in the dorsal raphe produces disease-related neuropathology but not depressive-like behaviors in wildtype mice. Brain Research. 1608: 177-90. PMID 25732261 DOI: 10.1016/J.Brainres.2015.02.027 |
0.384 |
|
| 2014 |
Monteys AM, Spengler RM, Dufour BD, Wilson MS, Oakley CK, Sowada MJ, McBride JL, Davidson BL. Single nucleotide seed modification restores in vivo tolerability of a toxic artificial miRNA sequence in the mouse brain. Nucleic Acids Research. 42: 13315-27. PMID 25332397 DOI: 10.1093/Nar/Gku979 |
0.783 |
|
| 2014 |
Dufour BD, Smith CA, Clark RL, Walker TR, McBride JL. Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 797-810. PMID 24390280 DOI: 10.1038/Mt.2013.289 |
0.764 |
|
| 2014 |
Wallace L, Liu J, Garwick-Coppens S, Guckes S, Smith C, McBride J, Harper S. G.P.10 Neuromuscular Disorders. 24: 797. DOI: 10.1016/J.Nmd.2014.06.024 |
0.664 |
|
| 2012 |
Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. Human Molecular Genetics. 21: 406-20. PMID 21997870 DOI: 10.1093/Hmg/Ddr475 |
0.685 |
|
| 2011 |
McBride JL, Pitzer MR, Boudreau RL, Dufour B, Hobbs T, Ojeda SR, Davidson BL. Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 2152-62. PMID 22031240 DOI: 10.1038/Mt.2011.219 |
0.801 |
|
| 2009 |
Hadaczek P, Forsayeth J, Mirek H, Munson K, Bringas J, Pivirotto P, McBride JL, Davidson BL, Bankiewicz KS. Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. Human Gene Therapy. 20: 225-37. PMID 19292604 DOI: 10.1089/Hum.2008.151 |
0.531 |
|
| 2009 |
Boudreau RL, McBride JL, Martins I, Shen S, Xing Y, Carter BJ, Davidson BL. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1053-63. PMID 19240687 DOI: 10.1038/Mt.2009.17 |
0.742 |
|
| 2009 |
Ramaswamy S, McBride JL, Han I, Berry-Kravis EM, Zhou L, Herzog CD, Gasmi M, Bartus RT, Kordower JH. Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease. Neurobiology of Disease. 34: 40-50. PMID 19150499 DOI: 10.1016/J.Nbd.2008.12.005 |
0.716 |
|
| 2008 |
Coryell MW, Wunsch AM, Haenfler JM, Allen JE, McBride JL, Davidson BL, Wemmie JA. Restoring Acid-sensing ion channel-1a in the amygdala of knock-out mice rescues fear memory but not unconditioned fear responses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13738-41. PMID 19091964 DOI: 10.1523/Jneurosci.3907-08.2008 |
0.41 |
|
| 2008 |
McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, Gilmore BL, Burstein H, Peluso RW, Polisky B, Carter BJ, Davidson BL. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proceedings of the National Academy of Sciences of the United States of America. 105: 5868-73. PMID 18398004 DOI: 10.1073/Pnas.0801775105 |
0.784 |
|
| 2007 |
Ramaswamy S, McBride JL, Kordower JH. Animal models of Huntington's disease. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 48: 356-73. PMID 17712222 DOI: 10.1093/Ilar.48.4.356 |
0.71 |
|
| 2007 |
Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, Lee SK, Shankar P, Manjunath N. Transvascular delivery of small interfering RNA to the central nervous system. Nature. 448: 39-43. PMID 17572664 DOI: 10.1038/Nature05901 |
0.506 |
|
| 2007 |
Ramaswamy S, McBride JL, Herzog CD, Brandon E, Gasmi M, Bartus RT, Kordower JH. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease. Neurobiology of Disease. 26: 375-84. PMID 17336076 DOI: 10.1016/J.Nbd.2007.01.003 |
0.787 |
|
| 2006 |
McBride JL, Ramaswamy S, Gasmi M, Bartus RT, Herzog CD, Brandon EP, Zhou L, Pitzer MR, Berry-Kravis EM, Kordower JH. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 9345-50. PMID 16751280 DOI: 10.1073/Pnas.0508875103 |
0.808 |
|
| 2006 |
McBride JL, Harper SQ, Staber PD, Martins IH, Burstein H, Peluso RW, Polisky B, Carter BJ, Davidson BL. 414. Non-Allele Specific RNA Interference in the CAG140 Knock-In Mouse Model of Huntington's Disease Molecular Therapy. 13: S159. DOI: 10.1016/J.Ymthe.2006.08.478 |
0.733 |
|
| 2006 |
Ramaswamy S, McBride J, Bartus R, Herzog C, Gasmi M, Brandon E, Zhou L, Berry-Kravis E, Kordower J. Gene therapy using AAV-neurturin (CERE-120) attenuates behavioral deficits and protects striatal neurons in models of Huntington's disease Experimental Neurology. 198: 586. DOI: 10.1016/J.Expneurol.2006.02.085 |
0.683 |
|
| 2004 |
McBride JL, Behrstock SP, Chen EY, Jakel RJ, Siegel I, Svendsen CN, Kordower JH. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. The Journal of Comparative Neurology. 475: 211-9. PMID 15211462 DOI: 10.1002/Cne.20176 |
0.458 |
|
| 2003 |
McBride JL, During MJ, Wuu J, Chen EY, Leurgans SE, Kordower JH. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. Experimental Neurology. 181: 213-23. PMID 12781994 DOI: 10.1016/S0014-4886(03)00044-X |
0.54 |
|
| 2002 |
McBride JL, Kordower JH. Neuroprotection for Parkinson's disease using viral vector-mediated delivery of GDNF. Progress in Brain Research. 138: 421-32. PMID 12432782 DOI: 10.1016/S0079-6123(02)38091-9 |
0.505 |
|
| 2000 |
Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (New York, N.Y.). 290: 767-73. PMID 11052933 DOI: 10.1126/Science.290.5492.767 |
0.577 |
|
| Show low-probability matches. |
